Jump to navigation
Multi-disciplinary care largely a pipe dream, study shows.
Methotrexate appears to at least delay RA onset.
First placebo-controlled trial suggests negligible difference in pain relief.
Many women are unaware of the risk of cardiovascular disease and how to to beat it.
Everyone else is cutting consumption.
In some cases the agents improve survival, a Cochrane review shows.
There's long waiting lists to find out if surgery is even needed.
Endocrine therapy may be justified beyond the standard timeframe
A long-term patient needs hospital care. But was her management evidence-based?
Sub-groups formerly considered at risk can get standard treatment.
Evidence is being ignored despite concern over harms and cost, researchers say.
Febuxostat linked to increased risk of cardiac and all-cause mortality.
The author requested the retractions.
Probably, but this should not affect treatment, specialist says.
There's less HPV genotype 11 being transmitted from mothers to babies.
An early bout of the viral infection can have lasting repercussions.
Good history-taking is vital for diagnosis, physicians say.
CPAP might slow dementia progression, researchers suggest.
While survival rates for most cancers continue to improve in Australia, brain cancers aren’t seeing the same success...
Dr Munjed Al Muderis reflects on a life-changing decision.
Australian Doctor Group (ADG) is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.